Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
Quick Stats
Jan 30, 202652.8
AI Score
HOLD1.08
Volume Ratio
Mar 12, 2026
Next Earnings
10
+ve Days (30d)
20
-ve Days (30d)
RLYB Stock Summary
Last updated Jan 30, 2026
RLYB is currently trading at $0.6421, positioned above its 200-day moving average of $0.53, indicating a long-term uptrend. The stock has a 52-week range of $0.2201 to $0.95.
Technical Analysis: The 50-day moving average stands at $0.69, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 43.701, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.032, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates RLYB at 52.8/100 with a HOLD recommendation.
RLYB (Rallybio Corporation Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 43.701 |
| CMF (20) | -0.032 |
| ROC (10) | -5.015 |
| ADX (14) | 21.101 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.014 |
| AROONOSC (14) | -35.714 |
| WILLAMS %R (14) | -62.119 |
| MFI (14) | 40.467 |
RLYB Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RLYB Price vs Max Options Open Interest
RLYB Max Change In Options Open Interest
RLYB Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RLYB Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RLYB Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RLYB Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Rallybio Corporation Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
RLYB Moving Averages Analysis
Rallybio Corporation Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
RLYB (Rallybio Corporation Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 0.66 |
| 20 | 0.68 |
| 30 | 0.7 |
| 50 | 0.69 |
| 100 | 0.64 |
| 200 | 0.53 |
RLYB Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 27.1 million |
| Earnings/Share ($) | -0.32 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.4933 |
| EPS Estimate Next Year ($) | -1.1467 |
| WallStreet Target Price ($) | 1 |
| Most Recent Quarter |